CLINICAL_TRIALS
trial_result
· 2025-12-16
Clinical Trial Update: A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease
Summary
This completed cross-sectional study from Zhujiang Hospital investigates the association between gut microbiota–derived peptidoglycan fragments and alcohol-asso…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Zhujiang Hospital | Conditions: Alcohol-associated Liver Disease | Status: COMPLETED